Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research report released on Saturday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Performance Eagle Pharmaceuticals stock opened at $0.85 on Friday. The company’s 50-day moving average is $0.84 and its 200-day moving […]
More Stories
Haemonetics (NYSE:HAE) Coverage Initiated at Robert W. Baird
Analysts at Robert W. Baird initiated coverage on shares of Haemonetics (NYSE:HAE – Get Free Report) in a report issued...
UBS Group Lowers General Mills (NYSE:GIS) Price Target to $49.00
General Mills (NYSE:GIS – Get Free Report) had its target price decreased by equities researchers at UBS Group from $52.00...
Elanco Animal Health (NYSE:ELAN) Upgraded at William Blair
Elanco Animal Health (NYSE:ELAN – Get Free Report) was upgraded by stock analysts at William Blair from a “market perform”...
Haemonetics (NYSE:HAE) Rating Increased to Strong-Buy at Baird R W
Baird R W upgraded shares of Haemonetics (NYSE:HAE – Free Report) to a strong-buy rating in a research report sent...
US Economy Shrank 0.5 Percent in First Quarter on Tariff-Linked Import Spike, Sluggish Spending
By Tom Ozimek The U.S. economy contracted at an annual rate of 0.5 percent in the first quarter of the...
Celebrities Flock to Venice for 3-Day Wedding of Jeff Bezos and Lauren Sánchez
By Elma Aksalic Celebrities are taking Venice by storm, as they arrive in droves for the wedding in Italy of...